Jong Rho

Dr. Rho is currently Professor of Pediatrics and Neurology, and Section Chief of Pediatric Neurology at the Yale School of Medicine. He received an undergraduate degree in molecular biophysics and biochemistry from Yale, and a M.D. from the University of Cincinnati (Ohio). Subsequently, he completed a pediatric neurology residency at UCLA and a research fellowship in neuropharmacology at the National Institutes of Health (NIH). Dr. Rho has held prior faculty appointments at the University of Washington (Seattle) and the Seattle Children’s Hospital, the University of California at Irvine, the Barrow Neurological Institute (Phoenix), University of Arizona and Arizona State University, the University of Calgary and the Alberta Children’s Hospital (Alberta, Canada), and most recently at the University of California San Diego and the Rady Children’s Hospital San Diego. Dr. Rho’s main research interests are the mechanisms underlying the anti-seizure and neuroprotective effects of metabolism-based treatments such as the ketogenic diet, and the neuropharmacology of anti-seizure medications. His research activities have been sponsored by the NIH, the Canadian Institutes for Health Research (CIHR), as well as diverse intramural and extramural public and private sector sources. Dr. Rho has served on the editorial boards of Epilepsia, Epilepsia Open, Seizure and Epilepsy Currents, and has been a regular reviewer of research grants submitted to the NIH and CIHR. In addition to an extensive list of publications in basic-translational neuroscience and pediatric neurology peer-reviewed journals, Dr. Rho has written numerous book chapters, edited several books, and is a popular national and international guest lecturer.